FHIR © HL7.org  |  Server Home  |  XIG Home  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - All Kinds, Realm US

18,284 resources

Type: Text:

By Version

By Authority

 

Start Prev Rows 6400 - 6600 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuth
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.727Tetracycline Allergy SCTactive2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.728Tetracycline Allergy Intoleranceactive2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.729Fluoroquinolones Allergy SCTactive2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.730Fluoroquinolone Allergy Intoleranceactive2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.731Penicillin Allergy RXNORMactive2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.732Penicillin Allergy SCTactive2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.733Penicillin Allergy Intoleranceactive2025-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.734PIM_Metformin_Single_Ingredient_Onlyactive2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.735PIM_Metformin_Combo_Ingredient_Onlyactive2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.737Pneumonia SCTactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.738Pneumoniaactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.739Pulmonary Embolism I10active2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.742Pulmonary Embolism SCTactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.743Pulmonary Embolismactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.744Influenza I10active2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.745Influenza SCTactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.746Influenza (Tests for influenza A or B virus Antigen)active2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.747Influenzaactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.748COVID 19 I10active2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.749COVID19 SCTactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.750COVID19active2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.752RSV I10active2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.753RSV SCTactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.754RSVactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.755Respiratory Rate SCTactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.756Respiratory Rate LOINCactive2024-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.757Respiratory Rateactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.758Acute Respiratory Failure I10active2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.759Acute Respiratory Failure SCTactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.760Acute Respiratory Failureactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.761Dyspnea SCTactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.762Dyspnea I10active2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.763Dyspneaactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.764Confusion I10active2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.765Confusion SCTactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.766Confusionactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.767Drowsiness SCTactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.768Drowsiness I10active2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.769Drowsinessactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.770Cyanosis I10active2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.771Cyanosis SCTactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.772Cyanosisactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.775Arterial oxygen saturation LOINCactive2024-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.776Arterial oxygen saturation SCTactive2024-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.777Arterial oxygen saturationactive2024-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.779PIM_Potassium_Supplementsactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.780PIM_PPIsactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.781PIM_Migraine_Medications_Abortiveactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.782PIM_Migraine_Medications_Preventiveactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.783PIM_Bisphosphonatesactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.784PIM_BPH_Medicationsactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.785PIM_Thyroid_Replacement_Medicationsactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.786PIM_Overactive_Bladder_Medicationsactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.787PIM_Topical_Acne_Medicationsactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.788PIM_Antidepressant_Anxiolytic_Medicationsactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.789Simple Knee Pain I10active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.790Simple Knee Pain SCTactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.791Simple Knee Painactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.792Simple Left Knee Pain SCTactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.793Simple Right Knee Pain SCTactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.794Simple Right Knee Pain I10active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.795Simple Left Knee Pain I10active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.796Simple Right Knee Painactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.797Simple Left Knee painactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.798Knee joint surgery CPTactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.799Knee joint surgery SCTactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.800Knee joint surgeryactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.801Knee Osteoarthritis I10active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.802Knee Osteoarthritis SCTactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.803Knee Osteoarthritisactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.804Osteoarthritis of right knee SCTactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.805Osteoarthritis of left knee SCTactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.806Osteoarthritis of right knee I10active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.807Osteoarthritis of left knee I10active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.808Osteoarthritis of right kneeactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.809Osteoarthritis of left kneeactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.810Hip Osteoarthritis SCTactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.811Hip Osteoarthritis I10active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.812Hip Osteoarthritisactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.813Hip joint surgery CPTactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.814Hip joint surgery SCTactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.815Hip joint surgeryactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.816Osteoarthritis of right hip I10active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.817Osteoarthritis of left hip I10active2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.818Osteoarthritis of right hip SCTactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.819Osteoarthritis of left hip SCTactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.820Osteoarthritis of right hipactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.821Osteoarthritis of left hipactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.823Aminoglycosidesactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.824Carbapenemsactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.826Monobactamsactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.827Penicillinsactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.828Antimycobacterialsactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.829Beta_lactamaseactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.830Cyclic lipopeptidesactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.831Lincosamidesactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.832Macrolidesactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.833Amphenicolactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.834Oxazolidinonesactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.835Fluoroquinolonesactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.836Sulfonamidesactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.837Tetracyclinesactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.838Phosphonicsactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.839Pleuromutilinactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.840Streptograminsactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.841Lipoglycopeptidesactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.842Nitroimidazolesactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.843PIM_Hyd_Bus_Mir_Traactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.844Nitrofuransactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.845Rifamycinsactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.846Glycylcyclineactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.847Pyrimidinesactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.849Antibiotics oral and parenteralactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.850Medications_hyperkalemiaactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.852Hyperkalemia_ICD10active2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.853Hyperkalemia_SCTactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.854Hyperkalemia Conditionsactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.855Medications_Chronic Hyperkalemiaactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.858PIM_Alpha_Blockers_2active2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.860PIM_Ambulatory_Visits_CPTsactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.862PIM_Ambulatory_Visits_SNOMEDactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.863PIM_Thyroid_Stimulating_Hormone_(TSH)active2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.864PIM_Triiodothyronine_(T3)active2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.865PIM_Thyroxine_(T4)active2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.866PIM_Magnesium_LOINCactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.867PIM_BMP_CMP_LOINCactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.868PIM_URIC_ACID_LOINCactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.869PIM_Migraine_Medicationsactive2025-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.870PIM_Triptansactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.871ICS_SABA Relieveractive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.873PIM_Asthma_COPD_Medsactive2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.874PIM_Lipid_Panel_CPTsactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.875PIM_Hepatic_Function_Panel_CPTsactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.876Alpha Glucosidase Allergy Intoleranceactive2025-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.877Inflammatory bowel disease I10active2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.878Inflammatory bowel disease SCTactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.879Inflammatory bowel diseaseactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.880Gastrointestinal obstruction SCTactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.881Gastrointestinal obstruction I10active2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.882Gastrointestinal obstructionactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.883DPP4i Allergy Intoleranceactive2025-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.884Multiple endocrine neoplasia type 2 (MEN II) SCTactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.885Multiple endocrine neoplasia type 2 (MEN II) I10active2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.886Multiple endocrine neoplasia type 2 (MEN II)active2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.887Gastroparesis SCTactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.888Gastroparesis I10active2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.889Gastroparesisactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.890Meglitinide Allergy Intoleranceactive2025-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.891Sulfonylurea Allergy Intoleranceactive2025-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.892Peripheral edema I10active2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.893Peripheral edema SCTactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.894Peripheral edemaactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.895TZD Allergy Intoleranceactive2025-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.896PIM_Beta_Blockersactive2024-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.897PIM_CCB_DHPsactive2024-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.898PIM_Loop_Diureticsactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.899PIM_Inhaled_Corticosteroids_(ICS)active2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.9ACE inhibitorsactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.90ASCVD I10active2023-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.900PIM_Leukotrienesactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.901OIA_Asthma_COPD_Meds_Inhalersactive2025-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.902OIA_Asthma_COPD_Meds_Nebulizersactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.903OIA_Asthma_COPD_Meds_Oralactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.904OIA_GLP1_Injectablesactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.905OIA_Insulin_Injectablesactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.906OIA_Oral_Hypoglycemicsactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.907OIA_DM1_DM2_Medsactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.908Medium Dose ICS Formoterolactive2024-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.909High Dose ICS Formoterolactive2024-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.910CKD stage5OrESRD I10active2024-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.911CKD stage5OrESRD SCTactive2024-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.912CKD stage5OrESRDactive2024-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.914Anxiety_I10active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.915Anxiety_SCTactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.916Anxietyactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.918Stress_SCTactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.919Stress_I10active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.920Stressactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.921PBH_Anxiety_SCTactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.922PBH_Depression_SCTactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.923PBH_Stress_SCTactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.924PBH_Insomnia_SCTactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.925PIM_CMP_CPTsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.926Canagliflozin medsactive2024-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.927Empagliflozin medsactive2024-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.928Dapagliflozin medsactive2024-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.929Ertugliflozin medsactive2024-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.930Dulaglutide medsactive2024-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.931Liraglutide medsactive2024-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.932Semaglutide SC medsactive2024-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.933T2DM meds benefitting ASCVDactive2024-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.934T2DM meds benefitting CKD stages 2, 3, and 4 with eGFR >= 20 mL/minactive2024-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.935T2DM meds benefitting CKD stage 5active2024-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.936T2DM meds benefitting HF with eGFR >= 20 mL/minactive2024-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.938Crohn disease SCTactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.939Crohn disease I10active2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.940Crohn diseaseactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.941Celiac disease SCTactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.942Celiac disease I10active2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.943Celiac diseaseactive2024-10hl7